Cue Biopharma (CUE) Short Interest Ratio & Short Volume $0.81 +0.02 (+3.04%) As of 09:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cue Biopharma Short Interest DataCue Biopharma (CUE) has a short interest of 863,100 shares, representing 1.28% of the float (the number of shares available for trading by the public). This marks a -22.24% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.7, indicating that it would take 2.7 days of the average trading volume of 260,630 shares to cover all short positions.Current Short Interest863,100 sharesPrevious Short Interest1,110,000 sharesChange Vs. Previous Month-22.24%Dollar Volume Sold Short$647.84 thousandShort Interest Ratio2.7 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares76,850,000 sharesShort Percent of Float1.28%Today's Trading Volume32,126 sharesAverage Trading Volume260,630 sharesToday's Volume Vs. Average12% Short Selling Cue Biopharma? Sign up to receive the latest short interest report for Cue Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCUE Short Interest Over TimeCUE Days to Cover Over TimeCUE Percentage of Float Shorted Over Time Cue Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025863,100 shares $647.84 thousand -22.2%1.3%2.7 $0.75 7/15/20251,110,000 shares $777 thousand -4.3%N/A3.5 $0.70 6/30/20251,160,000 shares $791.47 thousand +39.5%1.7%5.3 $0.68 6/15/2025831,600 shares $500.62 thousand +7.4%1.2%4 $0.60 5/31/2025774,100 shares $512.61 thousand -13.3%1.4%4.7 $0.66 5/15/2025892,700 shares $646.14 thousand +3.0%1.6%5 $0.72 4/30/2025867,100 shares $654.75 thousand -1.9%N/A5.1 $0.76 4/15/2025883,400 shares $706.72 thousand +3.7%1.6%4.5 $0.80 3/31/2025851,900 shares $776.08 thousand -0.9%1.5%3.8 $0.91 3/15/2025859,900 shares $822.84 thousand -10.0%1.5%3.3 $0.96 Get the Latest News and Ratings for CUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/28/2025955,200 shares $1.17 million -6.4%1.7%3.2 $1.23 2/15/20251,020,000 shares $1.52 million -7.3%1.8%3.2 $1.49 1/31/20251,100,000 shares $1.60 million +1.9%N/A2.6 $1.45 1/15/20251,080,000 shares $1.40 million -16.9%N/A2.2 $1.30 12/31/20241,300,000 shares $1.42 million +20.4%N/A2.1 $1.09 12/15/20241,080,000 shares $1.02 million +8.0%N/A1.4 $0.94 11/30/20241,000,000 shares $1.22 million -6.5%N/A1.3 $1.22 11/15/20241,070,000 shares $1.33 million -39.9%N/A1.4 $1.25 10/31/20241,780,000 shares $2.87 million -8.7%N/A2.6 $1.61 10/15/20241,950,000 shares $2.18 million -48.7%N/A2.9 $1.12 9/30/20243,800,000 shares $2.88 million +6.7%N/A6.6 $0.76 9/15/20243,560,000 shares $2.10 million +3.8%N/A8.2 $0.59 8/31/20243,430,000 shares $2.48 million -6.3%N/A7.7 $0.72 8/15/20243,660,000 shares $2.17 million -9.2%N/A8.1 $0.59 7/31/20244,030,000 shares $3.37 million +8.3%N/A8.9 $0.84 7/15/20243,720,000 shares $3.46 million -21.5%N/A9.7 $0.93 6/30/20244,740,000 shares $5.88 million +5.6%N/A12.3 $1.24 6/15/20244,490,000 shares $6.11 million +3.2%N/A15.9 $1.36 5/31/20244,350,000 shares $7.09 million -5.2%N/A15.5 $1.63 5/15/20244,590,000 shares $7.53 million -7.5%N/A15.5 $1.64 4/30/20244,960,000 shares $9.42 million +3.8%N/A17.2 $1.90 4/15/20244,780,000 shares $7.62 million +13.8%N/A18.7 $1.60 3/31/20244,200,000 shares $7.94 million +1.9%N/A15.8 $1.89 3/15/20244,120,000 shares $8.53 million +3.8%N/A14.7 $2.07 2/29/20243,970,000 shares $8.24 million +4.2%N/A12.7 $2.08 2/15/20243,810,000 shares $8.95 million +5.8%N/A10.8 $2.35 1/31/20243,600,000 shares $9.50 million -1.4%N/A10.6 $2.64 1/15/20243,650,000 shares $10.91 million +6.7%N/A10.1 $2.99 12/31/20233,420,000 shares $9.03 million +5.2%N/A9.4 $2.64 12/15/20233,250,000 shares $9.20 million +8.3%N/A9.5 $2.83HIDDEN IN THE BOOK OF GENESIS… (Ad)“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.Watch Jim Rickards reveal the Old Testament Wealth Code 11/30/20233,000,000 shares $7.50 million -1.0%N/A10 $2.50 11/15/20233,030,000 shares $7.21 million -2.6%N/A11.8 $2.38 10/31/20233,110,000 shares $6.53 million +19.6%N/A10.2 $2.10 10/15/20232,600,000 shares $5.33 million +2.4%N/A8.2 $2.05 9/30/20232,540,000 shares $5.84 million +2.8%N/A6.7 $2.30 9/15/20232,470,000 shares $6.32 million +1.2%N/A5.2 $2.56 8/31/20232,440,000 shares $6.61 million -20.3%N/A5 $2.71 8/15/20233,060,000 shares $8.60 million -5.9%N/A6.2 $2.81 7/31/20233,250,000 shares $12.42 million +30.0%N/A7.1 $3.82 7/15/20232,500,000 shares $11.13 million +28.2%N/A5.5 $4.45 6/30/20231,950,000 shares $7.12 million +142.2%N/A5.4 $3.65 6/15/2023805,200 shares $3.12 million +10.1%N/A2.5 $3.87 5/31/2023731,600 shares $2.93 million +36.2%N/A3 $4.00 5/15/2023537,100 shares $2.39 million +1.0%N/A2.4 $4.45 4/30/2023531,900 shares $2.30 million -21.6%N/A2.8 $4.33 4/15/2023678,200 shares $2.36 million -10.5%N/A4.8 $3.48 3/31/2023757,900 shares $2.71 million +35.4%N/A5.5 $3.57 3/15/2023559,600 shares $1.75 million +21.8%N/A4.4 $3.12 2/28/2023459,500 shares $1.29 million +4.9%N/A4.3 $2.80 2/15/2023438,000 shares $1.47 million -12.7%N/A3.9 $3.35 1/31/2023501,900 shares $1.72 million -22.1%N/A3.9 $3.42 1/15/2023644,500 shares $2.24 million +8.8%N/A5 $3.48 12/30/2022592,200 shares $1.69 million -17.4%N/A4.4 $2.85 12/15/2022717,000 shares $2.03 million -5.7%N/A4.4 $2.83 11/30/2022759,900 shares $2.93 million -12.9%N/A4.8 $3.86 11/15/2022872,100 shares $3.30 million -29.7%N/A5.4 $3.78 10/31/20221,240,000 shares $3.30 million -10.8%N/A7.6 $2.66 10/15/20221,390,000 shares $3.57 million -6.1%N/A8.2 $2.57 9/30/20221,480,000 shares $3.30 million -12.4%N/A8.2 $2.23 9/15/20221,690,000 shares $5.53 million -12.9%N/A6 $3.27 8/31/20221,940,000 shares $5.70 million No ChangeN/A6.1 $2.94 8/15/20221,940,000 shares $6.48 million -11.0%N/A5.5 $3.34 7/31/20222,180,000 shares $5.93 million -0.5%N/A5.5 $2.72 7/15/20222,190,000 shares $5.76 million -3.5%N/A5.2 $2.63 6/30/20222,270,000 shares $5.65 million -36.6%N/A4.8 $2.49 6/15/20223,580,000 shares $11.06 million -8.7%11.6%7.2 $3.09 5/31/20223,920,000 shares $15.17 million -4.6%12.7%8.3 $3.87 5/15/20224,110,000 shares $14.84 million No Change13.2%8.5 $3.61 4/30/20224,110,000 shares $16.28 million +15.1%13.2%8.5 $3.96 4/15/20223,570,000 shares $16.21 million +6.6%11.5%6.5 $4.54 3/31/20223,350,000 shares $16.35 million -12.3%10.8%6.3 $4.88 3/15/20223,820,000 shares $16.85 million +8.5%N/A8 $4.41 2/28/20223,520,000 shares $20.42 million +1.4%11.5%8.3 $5.80 2/15/20223,470,000 shares $24.64 million +29.0%11.3%8.2 $7.10 1/31/20222,690,000 shares $19.88 million +18.0%8.8%6.5 $7.39 1/15/20222,280,000 shares $22.69 million +11.8%7.4%6.9 $9.95 12/31/20212,040,000 shares $23.07 million +10.9%6.7%6.4 $11.31 12/15/20211,840,000 shares $20.68 million +10.8%6.0%5.8 $11.24 11/30/20211,660,000 shares $20.35 million -8.8%5.4%5.3 $12.26 11/15/20211,820,000 shares $32.49 million -9.9%5.9%6.1 $17.85HIDDEN IN THE BOOK OF GENESIS… (Ad)“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.Watch Jim Rickards reveal the Old Testament Wealth Code 10/29/20212,020,000 shares $24.66 million +3.1%6.8%7.8 $12.21 10/15/20211,960,000 shares $24.70 million -2.5%6.6%7.8 $12.60 9/30/20212,010,000 shares $29.29 million -15.6%6.8%8.6 $14.57 9/15/20212,380,000 shares $28.82 million -4.8%8.0%10.6 $12.11 8/31/20212,500,000 shares $29.98 million -2.0%8.4%12.7 $11.99 8/13/20212,550,000 shares $28.33 million -3.4%8.6%12.7 $11.11 7/30/20212,640,000 shares $27.51 million -2.2%8.9%6.2 $10.42 7/15/20212,700,000 shares $27.51 million -0.4%9.1%6.2 $10.19 6/30/20212,710,000 shares $31.57 million +1.5%9.1%6 $11.65 6/15/20212,670,000 shares $35.22 million -6.3%9.0%5.9 $13.19 5/28/20212,850,000 shares $40.87 million -5.3%9.6%6.1 $14.34 5/14/20213,010,000 shares $38.98 million +16.2%N/A6 $12.95 4/30/20212,590,000 shares $31.11 million -10.4%N/A5.3 $12.01 4/15/20212,890,000 shares $36.04 million -8.0%N/A9.3 $12.47 3/31/20213,140,000 shares $36.11 million +11.0%N/A10.1 $11.50 3/15/20212,830,000 shares $44.57 million +1.8%N/A8.5 $15.75 2/26/20212,780,000 shares $36.78 million +0.7%N/A8.8 $13.23 2/12/20212,760,000 shares $43.33 million -5.8%N/A9.3 $15.70 1/29/20212,930,000 shares $39.82 million +1.4%N/A10 $13.59 1/15/20212,890,000 shares $36.79 million +4.7%N/A9.8 $12.73 12/31/20202,760,000 shares $35.55 million +3.4%N/A10.4 $12.88 12/15/20202,670,000 shares $36.37 million -6.6%N/A10.4 $13.62 11/30/20202,860,000 shares $39.30 million -0.7%N/A10.8 $13.74 11/15/20202,880,000 shares $34.30 million +5.5%N/A10.3 $11.91 10/30/20202,730,000 shares $33.03 million +11.0%N/A10.3 $12.10 10/15/20202,460,000 shares $38.40 million -5.8%N/A9.3 $15.61 9/30/20202,610,000 shares $39.28 million +12.5%N/A9.9 $15.05 9/15/20202,320,000 shares $41.78 million +7.4%N/A7.5 $18.01 8/31/20202,160,000 shares $38.60 million -0.9%N/A6.6 $17.87 CUE Short Interest - Frequently Asked Questions What is Cue Biopharma's current short interest? Short interest is the volume of Cue Biopharma shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 863,100 shares of CUE short. 1.28% of Cue Biopharma's shares are currently sold short. Learn More on Cue Biopharma's current short interest. What is a good short interest ratio for Cue Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CUE shares currently have a short interest ratio of 3.0. Learn More on Cue Biopharma's short interest ratio. What is a good short interest percentage for Cue Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.28% of Cue Biopharma's floating shares are currently sold short. Is Cue Biopharma's short interest increasing or decreasing? Cue Biopharma saw a drop in short interest in the month of July. As of July 31st, there was short interest totaling 863,100 shares, a drop of 22.2% from the previous total of 1,110,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cue Biopharma's short interest compare to its competitors? 1.28% of Cue Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cue Biopharma: Larimar Therapeutics, Inc. (8.06%), Entrada Therapeutics, Inc. (5.13%), ProQR Therapeutics N.V. (0.39%), Adherex Technologies Inc. (5.56%), Design Therapeutics, Inc. (11.27%), Canopy Growth Corporation (14.13%), I-Mab Sponsored ADR (0.80%), AC Immune (2.44%), biote Corp. (2.90%), SOPHiA GENETICS SA (0.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Cue Biopharma stock? Short selling CUE is an investing strategy that aims to generate trading profit from Cue Biopharma as its price is falling. CUE shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cue Biopharma? A short squeeze for Cue Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CUE, which in turn drives the price of the stock up even further. How often is Cue Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CUE, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies LRMR Short Squeeze TRDA Short Squeeze PRQR Short Squeeze FENC Short Squeeze DSGN Short Squeeze CGC Short Squeeze IMAB Short Squeeze ACIU Short Squeeze BTMD Short Squeeze SOPH Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CUE) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cue Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access